Search Within

Sarat Chandarlapaty

  1. "Britta Weigelt"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (21)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (43)
  2. Breast Medicine Service (43)
  3. Department of Medicine (43)
  4. Department of Pathology and Laboratory Medicine (43)
  5. GDMT, Pathology and Laboratory Medicine (43)
  6. GSK Faculty (43)

More Groups

People
  1. Britta Weigelt (43)
  2. Jorge Reis-Filho (35)
  3. Fresia Pareja Zea (30)
  4. Pier Selenica (22)
  5. Hannah Wen (21)
  6. Edi Brogi (19)

More People

Years
  1. 2025 (7)
  2. 2024 (7)
  3. 2023 (5)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (10)

More Years

Publications
  1. Cancer Research (6)
  2. Laboratory Investigation (6)
  3. Annals of Oncology (5)
  4. Journal of Clinical Oncology (5)
  5. Modern Pathology (5)
  6. npj Breast Cancer (3)

More Publications

Publishers
  1. Nature Publishing Group (12)
  2. American Association for Cancer Research (8)
  3. American Society of Clinical Oncology (6)
  4. Nature Research (5)
  5. Oxford University Press (5)
  6. Cell Press (3)

More Publishers

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic landscape of breast cancer in elderly patients
    Journal Article

    Selenica, P.; Dopeso, H.; Repetto, M.; Basili, T.; Gazzo, A. M.; Schwartz, C. J.; Derakhshan, F.; Marra, A.; Ferrando, L.; Beets-Tan, R. G. H.; more...
    npj Breast Cancer (2025)

    Fulltext@MSK | Save
  • TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician's choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769)
    Meeting Abstract

    Traina, T. A.; Chen, Y.; Khoury, K.; Rugo, H. S.; Mayer, E. L.; Abdou, Y.; Melisko, M. E.; Pareja, F.; Weigelt, B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Ultrasensitive ctDNA monitoring during CDK4/6 inhibitor therapy for metastatic breast cancer
    Meeting Abstract

    Ah-Reum An, J.; Jasper, J.; Cabel, L.; Yildirim, S. Y.; da Silva, E. M.; Patel, R. K.; LaBella, M.; Teysir, J.; Mai, N.; Safonov, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Co-occurrence of PI3K pathway gene alterations in endometrial cancer molecular subtypes at the single cell level
    Meeting Abstract

    Da Cruz Paula, A.; Zhu, Y.; Brown, D.; Pareja, F.; de Oliveira, T. B.; Dopeso, H.; da Silva, E. M.; Chandarlapaty, S.; Abu-Rustum, N.; Reis, J.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Germline genetic alterations in homologous recombination deficiency/DNA damage response genes in breast cancer
    Meeting Abstract

    Keske, A.; Terraf, P.; Gazzo, A.; Repetto, M.; Schwartz, C.; Ross, D.; Zhang, H.; Chandarlapaty, S.; Wen, H.; Brogi, E.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Multimodal histopathologic models stratify hormone receptor-positive early breast cancer
    Journal Article

    Boehm, K. M.; El Nahhas, O. S. M.; Marra, A.; Waters, M.; Jee, J.; Braunstein, L.; Schultz, N.; Selenica, P.; Wen, H. Y.; Weigelt, B.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
    Journal Article

    Kudo, R.; Safonov, A.; Jones, C.; Moiso, E.; Dry, J. R.; Shao, H.; Nag, S.; da Silva, E. M.; Yildirim, S. Y.; Li, Q.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • A genomics-driven artificial intelligence–based model classifies breast invasive lobular carcinoma and discovers CDH1 inactivating mechanisms
    Journal Article

    Pareja, F.; Dopeso, H.; Wang, Y. K.; Gazzo, A. M.; Brown, D. N.; Banerjee, M.; Selenica, P.; Bernhard, J. H.; Derakhshan, F.; da Silva, E. M.; more...
    Cancer Research (2024)

    Fulltext@MSK | Save
  • CCNE1 amplification as marker of poor prognosis and novel therapeutic target in advanced breast cancer
    Meeting Abstract

    Marra, A.; Selenica, P.; Zhu, Y.; Safonov, A.; Razavi, P.; Roulston, A.; Koehler, M.; Curigliano, G.; Ross, D. S.; Weigelt, B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save